Keyphrases
Myeloproliferative Neoplasms
100%
Leukemic Transformation
100%
Hydroxyurea
40%
Risk Factors
20%
Leukemia
20%
Progressive Disease
20%
Clinical Features
20%
Monotherapy
20%
Ruxolitinib
20%
Laboratory Features
20%
High-grade B-cell Lymphoma
20%
Statistical Association
20%
Therapy-related
20%
Prospective Controlled Study
20%
Sequence of Therapy
20%
Chlorambucil
20%
Common Pathogenesis
20%
Secondary AML
20%
Therapy-related Neoplasms
20%
Medicine and Dentistry
Myeloproliferative Neoplasm
100%
Hydroxyurea
40%
Neoplasm
20%
Progressive Disease
20%
Monotherapy
20%
B-Cell Lymphoma
20%
Phosphorus 32
20%
Ruxolitinib
20%
Chlorambucil
20%
Secondary Acute Myeloid Leukemia
20%
Pipobroman
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloproliferative Neoplasm
100%
Hydroxycarbamide
40%
B Cell Lymphoma
20%
Phosphorus 32
20%
Chlorambucil
20%
Secondary Acute Myeloid Leukemia
20%
Pipobroman
20%
Disease
20%
Neoplasm
20%
Monotherapy
20%
Ruxolitinib
20%